adverse effects
CONCLUSION: Depressed HIV-seropositive outpatients respond to       nefazodone comparably to other outpatient populations and have few adverse       effects, suggesting that nefazodone may have a role in the treatment of       depression in HIV-seropositive patients.
CONCLUSION: Depressed HIV-seropositive  @OBJECT$  respond to       nefazodone comparably to other outpatient populations and  @PREDICAT$  few  @SUBJECT$ , suggesting that nefazodone may have a role in the treatment of       depression in HIV-seropositive patients.